{"id":"6c160ce0-f5ed-4031-ba7e-c69741c43ca2","arxiv_id":"2606.19602","paper_version":1,"verdict":"UNVERDICTED","confidence":"LOW","novelty_score":5.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":0,"one_line_summary":"ACIE deploys an agentic RAG system for clinical information extraction that reaches 96.5% acceptance by nuclear-medicine physicians verifying extractions against source passages in a lymphoma registry study.","lead":"The paper introduces ACIE, an on-premise agentic RAG pipeline deployed at University Medicine Essen that extracts clinical information from hundreds of heterogeneous patient documents and achieves 96.5% clinician acceptance across 7,326 verified judgments. A smart generalist might read it to see how retrieval-augmented systems must be re-architected for real hospital data that lacks metadata and spans temporal and cross-document dependencies.","discovery_kind":"new_application","skeptic_critique":{"model":"grok-4.3","headline":"Lymphoma registry evaluation at single site may not generalize beyond that disease and setting","rationale":"The reader's weakest_assumption precisely identifies the narrow evaluation scope as the point where the central claim is least secure. Because the abstract supplies no additional cross-domain evidence, this remains the single most load-bearing concern; the UNVERDICTED stance is therefore appropriate.","tokens_in":1630,"tokens_out":314,"duration_ms":10752,"concrete_test":"Re-run the identical ACIE pipeline on an independent, non-lymphoma registry (e.g., cardiology or solid-tumor oncology) at a second hospital, collecting at least 1,000 new physician judgments under the same verification protocol; if overall acceptance falls below 90% or per-type variance increases markedly, the 96.5% figure does not generalize.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The headline 96.5% acceptance (7,326 judgments) rests entirely on nuclear-medicine physician verification within one lymphoma registry at University Medicine Essen. For the central claim—that ACIE reliably extracts across heterogeneous patient contexts where standard RAG fails—to be load-bearing, the test distribution must be representative of document heterogeneity, temporal complexity, and missing-metadata regimes encountered elsewhere. Lymphoma cases often feature relatively standardized reporting templates and fewer cross-specialty dependencies; single-institution verification can also embed local conventions about what counts as a citable source. No cross-disease, multi-center, or external-registry results are referenced in the provided abstract.","agreement_with_reader":"agree"},"referee_report":{"model":"grok-4.3","summary":"The manuscript introduces ACIE, an on-premise agentic RAG pipeline for clinical information extraction from large sets of heterogeneous patient documents that lack complete metadata. It addresses failures of standard RAG on temporal reasoning and cross-document dependencies, describes architectural choices shaped by the metadata gap, and evaluates the system on an independent retrospective lymphoma registry at University Medicine Essen. Nuclear-medicine physicians verified every extracted value against cited sources, yielding 96.5% acceptance across 7,326 judgments with per-type rates from 80% to 99%.","tokens_in":1742,"tokens_out":431,"duration_ms":18563,"significance":"A large-scale, clinician-verified evaluation with per-type breakdowns is a methodological strength that could support practical deployment of agentic extraction systems if the results generalize. However, the single-site, single-disease design limits the assessed significance for the central claim that ACIE reliably handles heterogeneous contexts where standard RAG fails.","major_comments":[{"comment":"Evaluation section: The 96.5% acceptance rate (7,326 judgments) rests entirely on nuclear-medicine physician verification within one lymphoma registry at a single institution. No cross-disease, multi-center, or external-registry results are reported, which directly undermines the claim that the system succeeds across heterogeneous patient contexts, temporal complexity, and missing-metadata regimes.","section":"Evaluation"},{"comment":"Abstract and Methods: No quantitative baselines (standard RAG or other extractors), error analysis, or description of blinding in the verification process are provided. Without these, the per-type acceptance rates (80–99%) cannot be interpreted as evidence that ACIE improves on existing approaches.","section":"Abstract and Methods"}],"minor_comments":[{"comment":"The abstract could more explicitly state the architectural decisions and failure modes analyzed in the full text to better align with the title's promise of 'what works, what breaks, and why.'","section":"Abstract"}],"recommendation":"major_revision","confidential_remarks":null},"author_rebuttal":{"model":"grok-4.3","summary":"We thank the referee for the constructive comments. We address each major point below, noting where revisions to scope and content are warranted while preserving the manuscript's focus on the metadata gap and clinician-verified extraction in a complex real-world registry.","responses":[{"response":"We agree the single-institution, single-disease design limits broad generalization claims. The evaluated registry nevertheless contains highly heterogeneous documents per patient with absent metadata, directly exercising the temporal and cross-document challenges described. We will revise the abstract, introduction, and discussion to scope claims explicitly to this setting and add a limitations paragraph on the need for future multi-center studies. No new external data will be added.","revision_made":"yes","referee_comment":"[Evaluation] Evaluation section: The 96.5% acceptance rate (7,326 judgments) rests entirely on nuclear-medicine physician verification within one lymphoma registry at a single institution. No cross-disease, multi-center, or external-registry results are reported, which directly undermines the claim that the system succeeds across heterogeneous patient contexts, temporal complexity, and missing-metadata regimes."},{"response":"Clinician acceptance against source passages is the primary metric because exhaustive ground-truth labels are unavailable. We will add, in revision, a quantitative standard-RAG baseline on a sampled subset, a per-type error analysis, and an explicit Methods description of the verification process (including blinding to extraction method). These additions will appear in the Methods and Results sections.","revision_made":"yes","referee_comment":"[Abstract and Methods] Abstract and Methods: No quantitative baselines (standard RAG or other extractors), error analysis, or description of blinding in the verification process are provided. Without these, the per-type acceptance rates (80–99%) cannot be interpreted as evidence that ACIE improves on existing approaches."}],"tokens_in":1302,"tokens_out":399,"duration_ms":20820,"standing_objections":[]},"desk_editor":{"model":"grok-4.3","letter":"The paper's core result is a deployed on-premise pipeline (ACIE) that pulls structured values from full patient document collections and achieves 96.5% acceptance across 7,326 physician judgments, with type-specific rates from 80% to 99%. They also map out how missing metadata breaks ordinary RAG on temporal and cross-document tasks.\n\nWhat the work does cleanly is tie the architecture choices directly to the data problems they observed. The system reasons over complete contexts rather than isolated chunks and forces every extraction to cite its source passage. The evaluation sits on an independent retrospective registry with nuclear-medicine physicians checking every value against the cited text. That volume of verified judgments and the per-type breakdown are more than most clinical RAG papers provide.\n\nThe soft spot is the narrow test bed. All data come from one hospital and one disease area. Lymphoma reporting often follows relatively standardized templates, so the high acceptance numbers may not travel to messier multi-specialty or multi-center records where metadata gaps and cross-document dependencies look different. The abstract gives no baselines against non-agentic retrieval or details on blinding and selection of the verified cases.\n\nThis is useful reading for groups already running clinical extraction pilots who need to see how agentic routing and source grounding play out in practice. The empirical grounding is strong enough that a serious editor should send it to referees, even though the authors will have to tighten the scope claims and add comparisons in revision.","headline":"ACIE gives a concrete, clinician-verified look at agentic RAG for clinical extraction on one lymphoma registry, but the single-site scope keeps broader claims modest.","tokens_in":2241,"tokens_out":372,"would_cite":false,"duration_ms":15739,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"grok-4.3","headline":"An on-premise agentic RAG pipeline extracts clinical values from full patient records and achieves 96.5 percent clinician acceptance on verification.","keywords":["agentic RAG","clinical information extraction","patient context","lymphoma registry","metadata gap","clinician verification","on-premise deployment","temporal reasoning"],"falsifier":"A comparable verification study performed in a different disease area or hospital that yields acceptance rates substantially below 80 percent would show the reported performance does not hold.","tokens_in":2555,"feed_emoji":"🏥","tokens_out":665,"duration_ms":19452,"temperature":0.7,"pith_summary":"Patient records contain hundreds of documents and thousands of data points but lack the metadata needed for reliable retrieval. Standard RAG mishandles temporal reasoning and cross-document links, so the authors built ACIE, a configurable agentic RAG system that reasons over complete contexts and cites source passages for every output. They ran the system at a university hospital and tested it against an independent lymphoma registry in which physicians checked every extracted value. Across 7,326 judgments the clinicians accepted 96.5 percent of the extractions, with acceptance by type ranging from 80 to 99 percent. The work quantifies the metadata gap and shows how it drove specific architectural choices.","feed_headline":"Agentic RAG pipeline hits 96.5% clinician acceptance on extractions","feed_subtitle":"Handles hundreds of heterogeneous documents per patient where standard RAG fails, verified by physicians in lymphoma registry.","key_machinery":"The ACIE agentic RAG pipeline, which deploys configurable agents to handle missing document-level metadata, temporal reasoning, and cross-document dependencies while producing source-grounded outputs.","core_discovery":"ACIE is an on-premise agentic RAG pipeline that reasons over complete patient contexts and grounds every answer in source passages. When evaluated in a retrospective lymphoma registry study in which nuclear-medicine physicians independently verify every extracted value against its cited sources, the system records 96.5 percent acceptance across 7,326 judgments, with per-type rates between 80 and 99 percent.","pith_inferences":["The same configurable agent structure could be reused for new extraction tasks by changing only the agent instructions and verification templates.","High source-grounding rates suggest the pipeline could shorten the time physicians spend manually reviewing registry data.","Results from one disease registry leave open whether similar acceptance would appear in oncology, cardiology, or primary-care settings."],"forward_implications":["Clinicians receive every extraction together with the exact source passages needed for direct verification.","Acceptance rates vary by information type but remain above 80 percent even for the hardest categories.","The on-premise design satisfies clinical privacy constraints while still allowing full-context reasoning.","Quantifying the metadata gap directly informs which retrieval and reasoning components must be added."],"fun_headline_variants":["ACIE agentic RAG records 96.5% clinician acceptance","Physicians accept 96.5% of ACIE extractions in registry","96.5% acceptance for ACIE agentic RAG clinical data","On-premise ACIE pipeline shows 96.5% physician acceptance"],"cache_read_input_tokens":2112,"weakest_assumption_plain":"The lymphoma registry study and its physician verification process provide a representative and unbiased test of extraction quality that generalizes beyond the specific disease area and hospital setting.","fun_headline_variants_meta":{"raw":{"variants":["ACIE agentic RAG records 96.5% clinician acceptance","Physicians accept 96.5% of ACIE extractions in registry","96.5% acceptance for ACIE agentic RAG clinical data","On-premise ACIE pipeline shows 96.5% physician acceptance"]},"model":"grok-4.3","cost_usd":0.006619,"raw_usage":{"total_tokens":2977,"prompt_tokens":605,"num_sources_used":0,"completion_tokens":78,"cost_in_usd_ticks":66190500,"prompt_tokens_details":{"text_tokens":605,"audio_tokens":0,"image_tokens":0,"cached_tokens":64},"completion_tokens_details":{"audio_tokens":0,"reasoning_tokens":2294,"accepted_prediction_tokens":0,"rejected_prediction_tokens":0}},"tokens_in":605,"tokens_out":78,"duration_ms":12583,"temperature":1.0,"reasoning_tokens":2294,"cache_read_input_tokens":64,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-06-26T20:37:51.589948+00:00","model_set":{"reader":"grok-4.3"},"falsifier":"A comparable verification study performed in a different disease area or hospital that yields acceptance rates substantially below 80 percent would show the reported performance does not hold.","supporting_citations":[],"review_version":1}